EE200200312A - Uued Helicobacter pylori'ga seonduvad ained ja nende kasutamine - Google Patents
Uued Helicobacter pylori'ga seonduvad ained ja nende kasutamineInfo
- Publication number
- EE200200312A EE200200312A EEP200200312A EEP200200312A EE200200312A EE 200200312 A EE200200312 A EE 200200312A EE P200200312 A EEP200200312 A EE P200200312A EE P200200312 A EEP200200312 A EE P200200312A EE 200200312 A EE200200312 A EE 200200312A
- Authority
- EE
- Estonia
- Prior art keywords
- helicobacter pylori
- related substances
- pylori related
- new
- new helicobacter
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Cardiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9904581A SE9904581D0 (sv) | 1999-12-15 | 1999-12-15 | A novel helicobacter pylori-binding substance and use thereof |
| PCT/SE2000/002567 WO2001043751A1 (en) | 1999-12-15 | 2000-12-15 | Novel helicobacter pylori-binding substances and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE200200312A true EE200200312A (et) | 2003-06-16 |
Family
ID=20418126
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200200312A EE200200312A (et) | 1999-12-15 | 2000-12-15 | Uued Helicobacter pylori'ga seonduvad ained ja nende kasutamine |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20040086514A1 (et) |
| EP (1) | EP1237558A1 (et) |
| JP (1) | JP2003517015A (et) |
| CN (1) | CN100389773C (et) |
| AU (1) | AU783876B2 (et) |
| CA (1) | CA2392766A1 (et) |
| CZ (1) | CZ20021989A3 (et) |
| EE (1) | EE200200312A (et) |
| HU (1) | HUP0204243A3 (et) |
| IL (1) | IL150247A0 (et) |
| NO (1) | NO20022890L (et) |
| NZ (1) | NZ520111A (et) |
| PL (1) | PL356329A1 (et) |
| RU (1) | RU2283115C2 (et) |
| SE (1) | SE9904581D0 (et) |
| SK (1) | SK8152002A3 (et) |
| WO (1) | WO2001043751A1 (et) |
| ZA (1) | ZA200204251B (et) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9904581D0 (sv) * | 1999-12-15 | 1999-12-15 | A & Science Invest Ab | A novel helicobacter pylori-binding substance and use thereof |
| FI20010118A7 (fi) * | 2001-01-19 | 2002-07-20 | Carbion Oy | Uudet helicobacter pylori reseptorit ja niiden käyttö |
| FI20011403A7 (fi) * | 2001-06-29 | 2002-12-30 | Carbion Oy | Menetelmä ja koostumukset vatsan sairauksien hoitoon |
| JP2005504017A (ja) * | 2001-06-29 | 2005-02-10 | バイオティ セラピィーズ コープ | 少なくとも１種の糖含有阻害性物質の用途 |
| WO2003059924A1 (en) * | 2002-01-18 | 2003-07-24 | Biotie Therapies Corporation | Novel binding epitopes for helicobacter pylori and use thereof |
| DE60301677T2 (de) * | 2002-02-04 | 2006-07-06 | Kyowa Hakko Kogyo Co., Ltd. | Pharmazeutische und Lebenmittelzusammensetzungen mit einem Di- oder Oligosaccharid, das die Insulinfreisetzung steigert |
| EP2272522B1 (en) * | 2002-06-28 | 2017-09-06 | Nestec S.A. | Therapeutic compositions for use in prophylaxis or treatment of diarrheas |
| FI20021989A0 (fi) * | 2002-11-06 | 2002-11-06 | Halina Miller-Podraza | Korkean affiniteetin Helicobacter pylori-reseptorit ja niiden käyttö |
| US20080274557A1 (en) * | 2005-03-03 | 2008-11-06 | Indiana University Research And Technology | Permethylation Of Oligosaccharides |
| JP4677525B2 (ja) * | 2005-08-23 | 2011-04-27 | 国立大学法人 長崎大学 | ヘリコバクター・ピロリの空胞化毒素の検出試薬および検出方法 |
| FR2906808B1 (fr) * | 2006-10-10 | 2012-10-05 | Univ Nantes | Utilisation d'anticorps monoclonaux specifiques de la forme o-acetylee du ganglioside gd2 dans le traitement de certains cancers |
| JP5014018B2 (ja) * | 2006-10-18 | 2012-08-29 | 旭化成ケミカルズ株式会社 | ピロリ菌の抑制剤または静菌剤 |
| WO2008084561A1 (ja) | 2007-01-12 | 2008-07-17 | Shinshu University | α－Ｎ－アセチルグルコサミニル結合単糖誘導体を含有するピロリ菌増殖抑制剤 |
| EP2060257A1 (en) | 2007-11-08 | 2009-05-20 | Nestec S.A. | Prevention and treatment of secondary infections following viral infection |
| GB0817908D0 (en) | 2008-10-01 | 2008-11-05 | Univ Ghent | Blood group a/b/h determinant on type 1 core glycosphinglipids chain as recognition point for the fedf protein of f18-fimbriated enterotoxigenic |
| EP2345656B1 (en) * | 2008-10-10 | 2018-05-02 | The Noguchi Institute | N-acetylglucosaminyl beta-linked monosaccharide derivative as a helicobacter pylori bacterium proliferation inhibitor |
| WO2013164652A2 (en) * | 2012-05-04 | 2013-11-07 | Ineb-Instituto De Engenharia Biomédica | Microspheres |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1544908A (en) * | 1975-07-08 | 1979-04-25 | Chembiomed Ltd | Artificial oligosaccharide antigenic determinants |
| JPS57500609A (et) * | 1980-05-09 | 1982-04-08 | ||
| US4678747A (en) * | 1983-02-18 | 1987-07-07 | Sloan-Kettering Institute For Cancer Research | Monoclonal antibodies for detection of an H (O) blood group antigen |
| SE8304006D0 (sv) * | 1983-07-15 | 1983-07-15 | Karlsson Karl Anders | Forening och komposition for terapeutisk eller diagnostisk anvendning samt forfarande for terapeutisk behandling |
| DK17885D0 (da) * | 1985-01-14 | 1985-01-14 | Karlsson Karl Anders | Antiviralt middel |
| US4971905A (en) * | 1987-08-11 | 1990-11-20 | Pacific Northwest Research Foundation | Diagnosis of cancerous or precancerous conditions in human secretory epithelia by enzyme activity of β-1-3N-acetylglucosaminyltransferase |
| US4895838A (en) * | 1988-03-09 | 1990-01-23 | Trustees Of Boston University | Method for provoking angiogenesis by administration of angiogenically active oligosaccharides |
| US4957741A (en) * | 1988-08-02 | 1990-09-18 | Angio-Medical Corp. | Method for the treatment of gastric ulcer |
| US5877028A (en) * | 1991-05-29 | 1999-03-02 | Smithkline Diagnostics, Inc. | Immunochromatographic assay device |
| MX9304638A (es) * | 1992-07-31 | 1994-05-31 | Neose Pharm Inc | Composicion para tratar e inhibir las ulceras gastricas y duodenales. |
| EP0601417A3 (de) * | 1992-12-11 | 1998-07-01 | Hoechst Aktiengesellschaft | Physiologisch verträglicher und physiologisch abbaubarer, Kohlenhydratrezeptorblocker auf Polymerbasis, ein Verfahren zu seiner Herstellung und seine Verwendung |
| US6406894B1 (en) * | 1992-12-11 | 2002-06-18 | Glycorex Ab | Process for preparing polyvalent and physiologically degradable carbohydrate-containing polymers by enzymatic glycosylation reactions and the use thereof for preparing carbohydrate building blocks |
| US6300113B1 (en) * | 1995-11-21 | 2001-10-09 | New England Biolabs Inc. | Isolation and composition of novel glycosidases |
| DE4408248A1 (de) * | 1994-03-11 | 1995-09-14 | Hoechst Ag | Physiologisch verträgliche und physiologisch abbaubare Kohlenhydrat-Mimetika, ein Verfahren zur Herstellung und ihre Verwendung |
| US5679769A (en) * | 1994-03-15 | 1997-10-21 | Sloan-Kettering Institute For Cancer Research | Synthesis of asparagine-linked glycopeptides on a polymeric solid support |
| WO1995029927A2 (en) * | 1994-05-02 | 1995-11-09 | Biomira, Inc. | Process for preparation of glycosides of tumor-associated carbohydrate antigens |
| CA2231073A1 (en) * | 1995-09-29 | 1997-04-10 | Ossi Renkonen | Synthetic multivalent slex containing polylactosamines and methods for use |
| ATE357452T1 (de) * | 1996-01-30 | 2007-04-15 | Glycomimetics Inc | Sialyl-lewisa und sialyl lewisx epitop-analoge |
| US6841543B1 (en) * | 1996-01-31 | 2005-01-11 | President And Fellows Of Harvard College | Methods of inhibiting production of T helper type 2 cytokines in human immune cells |
| ES2281914T3 (es) * | 1996-06-10 | 2007-10-01 | Thomas Boren | Antigeno del grupo de union a adhesina de helicobacter pylori. |
| US6132994A (en) * | 1996-07-23 | 2000-10-17 | Seikagaku Corporation | Lactosamine oligosaccharides and method for producing the same |
| JPH1045602A (ja) * | 1996-07-31 | 1998-02-17 | Motoyasu Murakami | ヘリコバクター・ピロリ接着阻害剤またはインターロイキン−８産生阻害剤 |
| US6902903B1 (en) * | 1996-12-19 | 2005-06-07 | Chiron Corporation | Helicobacter pylori diagnostics |
| US6410057B1 (en) * | 1997-12-12 | 2002-06-25 | Samyang Corporation | Biodegradable mixed polymeric micelles for drug delivery |
| DE69840175D1 (de) * | 1997-12-12 | 2008-12-11 | Samyang Corp | Biologisch abbaubare gemischte polymerische mizellen zur genverabreichung |
| JP4318765B2 (ja) * | 1998-04-01 | 2009-08-26 | 雪印乳業株式会社 | ピロリ菌感染防御剤 |
| KR100460173B1 (ko) * | 1998-12-11 | 2004-12-04 | 겐 코오포레이션 | 헬리코박터 파일로리 정착 억제제 |
| US20010051349A1 (en) * | 2000-02-17 | 2001-12-13 | Glycominds Ltd. | Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof |
| US20030100508A1 (en) * | 1999-02-24 | 2003-05-29 | Maryline Simon | Carbohydrate epitope mimic compounds and uses thereof |
| WO2000070060A1 (en) * | 1999-05-18 | 2000-11-23 | University Of Iowa Research Foundation | Production of complex carbohydrates |
| AUPQ275799A0 (en) * | 1999-09-10 | 1999-10-07 | Luminis Pty Limited | Recombinant bacterium expressing an oligosaccharide receptor mimic |
| FI19992070A7 (fi) * | 1999-09-28 | 2001-03-29 | Carbion Oy | Uudet fukosyloidut oligosakkaridit ja menetelmä niiden valmistamiseksi |
| SE9904581D0 (sv) * | 1999-12-15 | 1999-12-15 | A & Science Invest Ab | A novel helicobacter pylori-binding substance and use thereof |
| FI20010118A7 (fi) * | 2001-01-19 | 2002-07-20 | Carbion Oy | Uudet helicobacter pylori reseptorit ja niiden käyttö |
| EP1417965A1 (en) * | 2002-11-07 | 2004-05-12 | Vereniging Voor Christelijk Wetenschappelijk Onderwijs | C-type lectin binding molecules, identification and uses thereof |
| WO2005107798A1 (en) * | 2004-05-11 | 2005-11-17 | De Staat Der Nederlanden, Vertegenwoordigd Door De Minister Van Vws | NEISSERIA MENINGITIDIS IgtB LOS AS ADJUVANT |
| AU2005327199A1 (en) * | 2004-07-09 | 2006-08-17 | Amaox, Inc. | Immune cell biosensors and methods of using same |
| WO2006093524A2 (en) * | 2004-07-16 | 2006-09-08 | The General Hospital Corporation | Antigen-carbohydrate conjugates |
-
1999
- 1999-12-15 SE SE9904581A patent/SE9904581D0/xx unknown
-
2000
- 2000-12-15 CZ CZ20021989A patent/CZ20021989A3/cs unknown
- 2000-12-15 EP EP00987920A patent/EP1237558A1/en not_active Withdrawn
- 2000-12-15 NZ NZ520111A patent/NZ520111A/en unknown
- 2000-12-15 CA CA002392766A patent/CA2392766A1/en not_active Abandoned
- 2000-12-15 AU AU24188/01A patent/AU783876B2/en not_active Ceased
- 2000-12-15 EE EEP200200312A patent/EE200200312A/et unknown
- 2000-12-15 PL PL00356329A patent/PL356329A1/xx not_active IP Right Cessation
- 2000-12-15 US US10/149,608 patent/US20040086514A1/en not_active Abandoned
- 2000-12-15 IL IL15024700A patent/IL150247A0/xx unknown
- 2000-12-15 WO PCT/SE2000/002567 patent/WO2001043751A1/en not_active Ceased
- 2000-12-15 RU RU2002118703/15A patent/RU2283115C2/ru not_active IP Right Cessation
- 2000-12-15 JP JP2001544888A patent/JP2003517015A/ja active Pending
- 2000-12-15 CN CNB008172927A patent/CN100389773C/zh not_active Expired - Fee Related
- 2000-12-15 HU HU0204243A patent/HUP0204243A3/hu unknown
- 2000-12-15 SK SK815-2002A patent/SK8152002A3/sk not_active Application Discontinuation
-
2002
- 2002-05-28 ZA ZA200204251A patent/ZA200204251B/en unknown
- 2002-06-17 NO NO20022890A patent/NO20022890L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20022890L (no) | 2002-08-15 |
| RU2002118703A (ru) | 2004-02-20 |
| SK8152002A3 (en) | 2002-11-06 |
| AU783876B2 (en) | 2005-12-15 |
| CN1411376A (zh) | 2003-04-16 |
| CN100389773C (zh) | 2008-05-28 |
| HUP0204243A2 (hu) | 2003-03-28 |
| PL356329A1 (en) | 2004-06-28 |
| WO2001043751A1 (en) | 2001-06-21 |
| ZA200204251B (en) | 2003-05-28 |
| CZ20021989A3 (cs) | 2002-10-16 |
| EP1237558A1 (en) | 2002-09-11 |
| RU2283115C2 (ru) | 2006-09-10 |
| HUP0204243A3 (en) | 2003-08-28 |
| CA2392766A1 (en) | 2001-06-21 |
| IL150247A0 (en) | 2002-12-01 |
| AU2418801A (en) | 2001-06-25 |
| JP2003517015A (ja) | 2003-05-20 |
| NZ520111A (en) | 2004-08-27 |
| SE9904581D0 (sv) | 1999-12-15 |
| US20040086514A1 (en) | 2004-05-06 |
| NO20022890D0 (no) | 2002-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE200200312A (et) | Uued Helicobacter pylori'ga seonduvad ained ja nende kasutamine | |
| NO20032753D0 (no) | Forbindelse og anvendelse derav | |
| NO20022334L (no) | Ny sammensetning og anvendelse | |
| DE59906436D1 (de) | Sulfid- und oxisulfidpigmente | |
| ATE260033T1 (de) | Biozide zusammensetzung und deren verwendung | |
| PT1019358E (pt) | 3,3-diarilpropilaminas sua utilizacao e sua preparacao | |
| PT1123441E (pt) | Composicoes e metodos para preparar dispersoes e metodos para utilizar as dispersoes | |
| IL138178A0 (en) | Identifiable marking compositions and methods | |
| EE200100347A (et) | 3,3-biarüülpiperidiini ja 2,2-biarüülmorfoliini derivaadid | |
| FI20010118A7 (fi) | Uudet helicobacter pylori reseptorit ja niiden käyttö | |
| HUP0103270A3 (en) | Method and device for obtaining vegetal fibre material and the use thereof | |
| BR9708248A (pt) | Benzotiofenos formulações contendo os mesmos e metódos | |
| BR9707657A (pt) | Benzotiofenos formulações contendo os mesmos e métodos | |
| BR9700243A (pt) | Fecho tipo zíper | |
| DE59901532D1 (de) | Pigmentzubereitungen in Granulatform | |
| NO20004284D0 (no) | Antikorrosjonspigment og anvendelse derav | |
| FI980566L (fi) | Uusi täyteaine ja pigmentti | |
| FI982249A0 (fi) | Petimateriaali ja polttomenetelmä | |
| EE9800085A (et) | 3,5-difluoropüridiinid, nende valmistamismeetod, herbitsiidne kompositsioon ja nende kasutamine | |
| EP1107250A4 (en) | RECORDER | |
| EP1267816A4 (en) | USE OF XANTHAN GUM TO THICKEN CL02 AND RELATED CLASSES | |
| EP1071434A4 (en) | CNRE BINDING FACTORS AND CORRESPONDING USES | |
| FI980680L (fi) | Rakenne ja sen käyttö | |
| FI942331L (fi) | Biosidisia koostumuksia ja niiden käyttö | |
| IT1298879B1 (it) | Composizione per impiego odontoiatrico e procedimento per la sua applicazione |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HD1A | Correction of address |